Watch today's Mayo Clinic Minute More than 5 million Americans are living with Alzheimer's disease. There is no cure, however, early and accurate diagnosis of this progressive form of dementia allows patients and families to prepare for the future. Vivien Williams has more in this Mayo Clinic Minute. Show More Summary
Watch today's Mayo Clinic Minute Alzheimer's disease affects millions of Americans and their families. Caring for a person with this progressive disease can be physically and emotionally challenging. As Mayo Clinic Alzheimer's Disease Research Center Director Dr. Show More Summary
Researchers are working on the assessment of patterns of autoantibodies in the blood as a way to determine progression towards Alzheimer's disease and other age-related conditions. The levels of these autoantibodies appear to reflect...Show More Summary
WATCH ANIMATION Lewy body dementia may not be as well-known as Alzheimer's disease, but is the second-most progressive form of dementia after Alzheimer's disease. It causes a progressive decline in mental and physical abilities. What is Lewy body dementia and what are its symptoms? Mayo Clinic neuropathologist Dr. Dennis Dickson says, "Lewy body dementia is a prototypical […]
Progress in using antibodies to clear plaques in Alzheimer's disease is slow because of inflammatory side effects in the brain. Now, a new study suggests a way forward.
An estimated seven to ten million people worldwide are living with Parkinson's disease (PD). More than half of PD patients develop progressive disease showing signs of dementia similar to Alzheimer's disease. A research team has discovered that non-inheritable PD may be caused by functional changes in the immune regulating gene Interferon-beta. Show More Summary
More and more data from preclinical and clinical studies strengthen the hypothesis that immune system-mediated actions contribute to and drive pathogenesis in Alzheimer’s disease. New insights suggest that A? indeed induces a strongShow More Summary
"This study has let us characterize the parameters of decline in people who will eventually develop Alzheimer's, which means we can better identify both benign symptoms and those that warrant particular attention." - Sylvie Bellevil...
By +Alzheimer's Reading Room A naturally occurring compound found in dark chocolate and red wine might be able to slow or stop the progress of Alzheimer’s disease. A compound in red wine, resveratrol, that appears to have anti-aging effects could become a new way to treat Alzheimer's disease, early research suggests. Show More Summary
A new study has found tantalizing evidence that a highly concentrated form of a compound found in red wine and dark chocolate might be able to slow the progression of Alzheimer’s disease.But it’s likely that it’s because the compound is tricking the body into acting as if it’s not eating at all.Read full article >>
While not proving that dementia can be “caught”, the explosive findings provide the first evidence of its transmission in humans via microscopic protein molecules. These days Alzheimer’s is recognised as a progressive neurological condition that mostly arises in the old. Thanks to new medical techniques cancer breakthroughs are improving patients’ chances all the time. Britain
MRI scans and other tools to detect and diagnose dementia are helpful but not definitive. A new report evaluates how well different types of brain imaging tests work to detect Alzheimer's and predict how the disease will progress.The...Show More Summary
People with Alzheimer’s disease have fat deposits in the brain, which may help to explain the progression of the disease. Researchers affiliated with the University of Montreal Hospital Research Centre (CRCHUM) have discovered accumulations of fat droplets in the brain of patients who died from the disease and have identified the nature of the fat. This […]
Right now, there is only symptomatic treatment for Alzheimer’s disease, which does not stall the progress of the disease. Nor does this approach provide insights on the causes. But if findings from recent research studies are to be weighed upon, this is about to change. Alzheimer’s disease (AD) is a curse, both for the person […]
A new meta-analysis of 323 studies looks at 93 possible factors associated with the risk of developing Alzheimer’s disease (AD). AD is a neurodegenerative disorder affecting the entire brain that causes a slowly progressive dementia over years. Dementia is a generic term for a chronic disorder of memory and cognition. AD is a specific disease [...]
In today's Mayo Clinic Minute with Vivien Williams: Alzheimer's disease progresses faster in women than men, gender differences in concussion symptoms and time is of the essence when it comes to treating strokes. Click here for more on the Alzheimer's study, here for research on concussions and here for more on strokes. Show More Summary
A protein involved in the progression of Alzheimer's disease also has properties that could be helpful for human health, a research study has found. The discovery helps researchers better understand the complicated brain chemistry behind the development of Alzheimer's disease.
Pharmaceutical researchers on Wednesday presented new data from the clinical trials of three drugs that, the scientists said, show promise for slowing the progression of Alzheimer’s disease.Researchers presented new analyses of research data on drugs produced by Eli Lilly, Roche and Biogen. Show More Summary
I experienced the worst and best customer service experiences of my life from competing companies on the same day a few years ago. My widowed father's Alzheimer's disease had progressed to the point where he could no longer remain in an independent living apartment in his over-60 community. Show More Summary
Above, Dr. Matthew Norton, head of policy at Alzheimer’s Research UK, discusses the new drug. Scientists appear to have made a breakthrough in the battle against Alzheimer’s disease after announcing test results for a drug that appears...Show More Summary